Anzeige
Mehr »
Freitag, 26.09.2025 - Börsentäglich über 12.000 News
Hot Stock: KI-Boom treibt Kupfer in neue Dimensionen - jetzt profitieren!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A401UY | ISIN: US36151G6008 | Ticker-Symbol: 12Q0
Lang & Schwarz
26.09.25 | 07:00
1,475 Euro
-100,00 % -1,475
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
INTELLIGENT BIO SOLUTIONS INC Chart 1 Jahr
5-Tage-Chart
INTELLIGENT BIO SOLUTIONS INC 5-Tage-Chart
RealtimeGeldBriefZeit
1,4601,49007:00

Aktuelle News zur INTELLIGENT BIO SOLUTIONS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
14:54Intelligent Bio Solutions updates FDA 510(k) timeline for drug test2
INTELLIGENT BIO SOLUTIONS Aktie jetzt für 0€ handeln
14:36Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Advances Preparations and Provides Updated Timeline for Anticipated FDA 510(k) Submission and Clearance89The Company is initiating clinical studies to further validate Intelligent Fingerprinting Drug Screening System INBS anticipates FDA 510(k) clearance in the second half of 2026 NEW YORK, Sept. 26...
► Artikel lesen
DoIntelligent Bio Solutions verlängert Laufzeit von Optionsscheinen der Serie H-1 bis März 20264
DoINTELLIGENT BIO SOLUTIONS INC. - 8-K, Current Report4
17.09.Intelligent Bio Solutions faces FDA request for new 510(k) submission4
17.09.INTELLIGENT BIO SOLUTIONS INC. - 8-K, Current Report2
17.09.Intelligent Bio Solutions: FDA fordert neuen 510(k)-Antrag für Drogenscreening-System4
17.09.Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Provides Update on FDA 510(k) Clearance Process for Intelligent Fingerprinting Drug Screening System131NEW YORK, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing...
► Artikel lesen
19.08.Intelligent Bio Solutions rise on record cartridge sales4
19.08.Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Achieves Record Monthly Sales of 12,500+ Units of Higher-Margin Cartridges in July150NEW YORK, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing...
► Artikel lesen
15.08.INTELLIGENT BIO SOLUTIONS INC. - 8-K, Current Report6
15.08.Intelligent Bio Solutions GAAP EPS of -$2.00, revenue of $3.05M4
15.08.Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Reports Fiscal 2025 Fourth Quarter and Full Year Results, Highlighting Progress on Planned U.S. Market Expansion, Revenue Growth and Increased Operational Efficiencies186Company advanced efforts to secure U.S. FDA 510(k) clearance to advance on path towards planned U.S. market expansion beyond Forensic Use Only settings Fourth quarter sequential and year-on-year revenue...
► Artikel lesen
15.08.INTELLIGENT BIO SOLUTIONS INC. - 10-K, Annual Report2
07.08.Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Announces Preliminary Fiscal Fourth Quarter Revenue with Double-Digit Sequential and Year-Over-Year Growth and Strong Operational Momentum157Company anticipates fiscal fourth quarter sequential and year-on-year revenue growth of approximately 16% Company advanced efforts to secure U.S. FDA 510(k) clearance for planned U.S. market entry...
► Artikel lesen
07.08.EXCLUSIVE: Intelligent Bio Expects Double Digit Topline Growth In Q43
06.08.INTELLIGENT BIO SOLUTIONS INC. - 8-K, Current Report3
06.08.Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Strengthens FDA 510(k) Package with New Cybersecurity and Performance Data Ahead of Planned U.S. Market Launch235NEW YORK, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing...
► Artikel lesen
30.07.London transport operator selects INBS for drug screening system3
30.07.Intelligent Bio Solutions secures drug testing tender with a London transport operator4
Weiter >>
64 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,7